<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23953" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Krukenberg Tumor</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aziz</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>University of Toledo Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Killeen</surname>
            <given-names>Robert B.</given-names>
          </name>
          <aff>University of Illinois</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Carlson</surname>
            <given-names>Karen</given-names>
          </name>
          <aff>University of Nebraska Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kasi</surname>
            <given-names>Anup</given-names>
          </name>
          <aff>University of Kansas</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Aziz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robert Killeen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Karen Carlson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anup Kasi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>4</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23953.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Krukenberg tumor is a metastatic&#x000a0;signet-ring cell adenocarcinoma of the ovary characterized by mucin-rich, signet-ring cells, originating from a gastrointestinal primary in 70% of cases, but also involving the colon, breast, appendix, and biliary tract. The incidence of Krukenberg tumors ranges from 1% to 21%, most common in Asian countries due to the increased prevalence of gastric cancer.&#x000a0;Krukenberg tumors are often bilateral and can be solid, cystic, or a combination. Immunohistochemistry stains can help distinguish Krukenberg from primary ovarian cancer. Because Krukenburg tumors present with nonspecific symptoms, the diagnosis is frequently delayed. Krukenberg tumors occur in younger women compared with an ovarian primary. The prognosis is poor,&#x000a0;but an overall survival benefit has been shown with palliative surgical resection.</p>
        <p>This course provides a comprehensive overview of Krukenberg tumors, focusing on epidemiology, clinical presentation, evaluation, and treatment. Participants will gain insights into the diverse origins of these tumors, and emphasis is placed on the challenges in timely diagnosis due to nonspecific symptoms, highlighting the need for vigilant clinical evaluations. Additionally, clinicians will delve into the significance of tumor markers in prognosis and treatment decisions. The course concludes with a nuanced discussion of treatment strategies, encompassing surgery, chemotherapy, targeted immunotherapy, and radiation, acknowledging the absence of standardized guidelines and the importance of an individualized, interdisciplinary approach. The course equips healthcare professionals with the knowledge and tools necessary to navigate the complexities of Krukenberg tumors and optimize patient care outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Apply&#x000a0;screening protocols for patients at risk, emphasizing early detection and timely intervention in the presence of nonspecific symptoms associated with Krukenberg tumors</p></list-item><list-item><p>Identify key clinical indicators and imaging features to promptly recognize Krukenberg tumors, distinguishing them from primary ovarian malignancies.</p></list-item><list-item><p>Implement evidence-based treatment strategies, including surgery and chemotherapy, tailored to the individual patient's tumor biology and functional status.</p></list-item><list-item><p>Collaborate with an interdisciplinary team, including oncologists, radiologists, and pathologists, to ensure a holistic and coordinated approach to Krukenberg tumor management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23953&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23953">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23953.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Krukenberg tumor&#x000a0;is named after Friedrich Ernst Krukenberg (1871-1946), who reported what he thought was a newly identified primary ovarian cancer but was&#x000a0;instead found to be a malignancy metastatic to the ovary. In much of the world, roughly&#x000a0;10% of ovarian tumors are metastatic disease, of which nearly half are Krukenberg tumors. However, the incidence of Krukenberg tumors&#x000a0;in Japan, Korea, and China is approximately 18% due to their greater prevalence of gastric cancer.<xref ref-type="bibr" rid="article-23953.r1">[1]</xref><xref ref-type="bibr" rid="article-23953.r2">[2]</xref><xref ref-type="bibr" rid="article-23953.r3">[3]</xref></p>
        <p>Many Krukenberg tumors arise from the stomach, but they may also originate from the appendix, breast, colon, small bowel, gallbladder, pancreas, and genitourinary system. Spread is&#x000a0;often via lymphatics but can be hematogenous or through direct invasion, depending in part on the proximity of the primary cancer to the ovaries and lymph nodes. On occasion, the primary tumor cannot be found.<xref ref-type="bibr" rid="article-23953.r4">[4]</xref>&#x000a0;The symptoms from Krukenberg tumor may be the first indication of cancer. Krukenberg tumors may cause&#x000a0;pain, bloating, and ascites, as well as irregular vaginal bleeding and dyspareunia. In addition, the tumors may induce changes within the ovarian stroma, resulting in hormone production.<xref ref-type="bibr" rid="article-23953.r4">[4]</xref></p>
        <p>Treatment of Krukenberg tumor is predicated on the biology of the primary cancer, and the prognosis is less favorable compared with other types of ovarian metastases or primary ovarian tumors. The mean survival following diagnosis is 14 months.<xref ref-type="bibr" rid="article-23953.r5">[5]</xref>&#x000a0;Both surgery and pharmacologic therapy have roles in extending overall survival in some patients with Krukenberg tumors. Treatment of this advanced disease requires careful consideration of multiple factors, including tumor site of origin, extent of metastatic spread, and functional status of the patient.</p>
      </sec>
      <sec id="article-23953.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Krukenberg tumor&#x000a0;originates in the stomach in about 70% of cases and is most commonly adenocarcinoma of the pylorus. The second most common origin site of Krukenberg tumor is the colon, and this site appears to be increasing in prevalence.<xref ref-type="bibr" rid="article-23953.r4">[4]</xref><xref ref-type="bibr" rid="article-23953.r6">[6]</xref>&#x000a0;Gastric and colorectal cancers together account for almost 90% of primary sites of Krukenberg tumor. Less common primary sites are the breast and appendix. Rare sources include the small bowel, gallbladder, ureter, urinary bladder, biliary tract, pancreas, ampulla of Vater, and cervix.<xref ref-type="bibr" rid="article-23953.r1">[1]</xref><xref ref-type="bibr" rid="article-23953.r2">[2]</xref><xref ref-type="bibr" rid="article-23953.r7">[7]</xref><xref ref-type="bibr" rid="article-23953.r8">[8]</xref><xref ref-type="bibr" rid="article-23953.r9">[9]</xref></p>
      </sec>
      <sec id="article-23953.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Krukenberg tumors occur in 5% to 10% of women with gastric cancer, many of whom are not diagnosed until their disease is advanced. The incidence is higher in Korea, Japan, and China, where these tumors make up about 20% of all ovarian cancers due to the high prevalence of signet-ring cell gastric cancer in these areas.<xref ref-type="bibr" rid="article-23953.r10">[10]</xref></p>
        <p>The median age of a patient diagnosed with Krukenberg tumor is&#x000a0;48 years, with a range of 27 to 65 years.<xref ref-type="bibr" rid="article-23953.r4">[4]</xref>&#x000a0;Patients with primary gastrointestinal tract tumors are the oldest group presenting with Krukenberg, whereas those with breast cancer are the youngest.<xref ref-type="bibr" rid="article-23953.r1">[1]</xref>&#x000a0;Ovarian metastases occur in younger women than&#x000a0;those who have primary ovarian malignancies;&#x000a0;the enhanced ovarian blood supply in younger women may make the ovary more prone to metastatic disease during this time. Additionally, gastric adenocarcinomas in younger women are typically of the signet-ring type, and&#x000a0;these have a predilection to metastasize to the ovary.<xref ref-type="bibr" rid="article-23953.r4">[4]</xref><xref ref-type="bibr" rid="article-23953.r11">[11]</xref></p>
        <p>Krukenberg tumors can be&#x000a0;synchronous, where the metastasis is discovered within&#x000a0;3 months of the diagnosis of the primary tumor, or metachronous, where the metastasis is found after&#x000a0;3 months, frequently after the completion of initial therapy.<xref ref-type="bibr" rid="article-23953.r12">[12]</xref>&#x000a0;Ovarian metastases&#x000a0;can occur years after the primary cancer has been treated.&#x000a0;Kukenberg tumors are bilateral in 80% of cases and are the most common bilateral metastatic tumor of the ovaries. Compared to primary ovarian cancers, they are less responsive to systemic chemotherapy. The ovarian site of metastatic disease is less responsive than synchronous metastases in different locations.&#x000a0;The overall survival remains under&#x000a0;1 year from the time of diagnosis.<xref ref-type="bibr" rid="article-23953.r10">[10]</xref><xref ref-type="bibr" rid="article-23953.r13">[13]</xref><xref ref-type="bibr" rid="article-23953.r14">[14]</xref><xref ref-type="bibr" rid="article-23953.r15">[15]</xref></p>
      </sec>
      <sec id="article-23953.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Malignant tumor spread to the ovary is thought to occur via lymphogenous, hematogenous, and transcoelomic routes.<xref ref-type="bibr" rid="article-23953.r16">[16]</xref><xref ref-type="bibr" rid="article-23953.r8">[8]</xref>&#x000a0; The younger age of a typical patient diagnosed with Krukenberg tumor corresponds&#x000a0;to a robust blood supply to&#x000a0;the ovaries,&#x000a0;supporting a mechanism for hematogenous spread. The short distance from the receptaculum chyli to gastric, hepatic, mesenteric, and pancreatic nodes allows for the ready passage of malignant cells to the urogenital lymph vessel trunks that feed the ovaries. The&#x000a0;lesser incidence of peritoneal involvement of Krukenberg tumors&#x000a0;suggests&#x000a0;the transcoelomic&#x000a0;route is not as common.<xref ref-type="bibr" rid="article-23953.r16">[16]</xref></p>
        <p>Lymphogenous spread is thought to be more prevalent from a gastric primary, where there is a short distance from gastric lymph nodes to ovarian lymph conduits. Gastric primary tumors are&#x000a0;often found within the mucosa and submucosa, sites of rich lymphatic networks. Studies have correlated the extent of gastric lymph node involvement with the prevalence of ovarian metastasis.<xref ref-type="bibr" rid="article-23953.r4">[4]</xref><xref ref-type="bibr" rid="article-23953.r17">[17]</xref><xref ref-type="bibr" rid="article-23953.r16">[16]</xref><xref ref-type="bibr" rid="article-23953.r8">[8]</xref>&#x000a0;In contrast, there appears to be a higher degree of malignant vascular invasion in metastases from a colonic primary.<xref ref-type="bibr" rid="article-23953.r18">[18]</xref><xref ref-type="bibr" rid="article-23953.r16">[16]</xref><xref ref-type="bibr" rid="article-23953.r19">[19]</xref>&#x000a0;</p>
        <p>During pregnancy, the hormonal milieu can facilitate cancer spread. Placental growth factor levels are&#x000a0;elevated in gastric cancer and are associated with serosal invasion and lymph node metastases. In addition, the state of pregnancy may delay the cancer diagnosis as the enlarging abdomen is attributed to the pregnancy.<xref ref-type="bibr" rid="article-23953.r12">[12]</xref><xref ref-type="bibr" rid="article-23953.r20">[20]</xref><xref ref-type="bibr" rid="article-23953.r21">[21]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-23953.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologically, Krukenberg tumor is characterized by mucin-laden signet ring cells with offset, hyperchromatic nuclei. The cytoplasmic mucin&#x000a0;within signet ring cells is necessary for diagnosis. The cytoplasm of the signet ring cells may be diffusely granular with eosinophilic bodies, largely vacuolated, or a combination featuring a large vacuole containing a drop of mucin, creating an eosinophilic body. Many patterns of signet ring cell organization are possible even within the same tumor. When arranged in tubules, the tumors are classified as&#x000a0;tubular Krukenberg.&#x000a0;</p>
        <p>The intracytoplasmic mucins of the signet ring are neutral and acidic and stain with Mayer mucicarmine, periodic acid-Schiff-Alcian blue stain with diastase digestion.<xref ref-type="bibr" rid="article-23953.r8">[8]</xref>&#x000a0;Krukenberg tumors stain positive for epithelial marker cytokeratin AE1/AE3 and epithelial membrane antigen and negative for inhibin and vimentin.<xref ref-type="bibr" rid="article-23953.r1">[1]</xref><xref ref-type="bibr" rid="article-23953.r2">[2]</xref>&#x000a0;One-third of patients will have either a positive cytokeratin 7 or cytokeratin 20; one-quarter will have elevated carcinoembryonic antigen (CEA) or cancer antigen 125 (CA-125).<xref ref-type="bibr" rid="article-23953.r11">[11]</xref>&#x000a0;</p>
        <p>Krukenberg tumor induces a sarcomatoid proliferation of ovarian stroma and produces a variable&#x000a0;ovarian stromal invasion by poorly differentiated adenocarcinoma. The stroma contains a mixture of spindle-shaped and round cells with minimal atypia.&#x000a0;The ovarian stroma&#x000a0;impacted by&#x000a0;the Krukenberg tumor can be mildly swollen or diffusely edematous to the extent that cellular features are blurred.&#x000a0;</p>
      </sec>
      <sec id="article-23953.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Krukenberg tumor may remain asymptomatic until size or hormonal changes create symptoms. The symptoms related to Krukenberg tumor may be the first clinical signs of a malignancy. The signs and symptoms of&#x000a0; Krukenberg tumor are nonspecific and may include increased abdominal girth, fatigue, abdominal and pelvic pain, abnormal uterine bleeding, hirsutism and virilization, and dyspareunia.<xref ref-type="bibr" rid="article-23953.r4">[4]</xref><xref ref-type="bibr" rid="article-23953.r11">[11]</xref>&#x000a0;</p>
        <p>Ascites, typically a late feature of peritoneal metastases, can occur alongside intestinal obstruction and cachexia. When Krukenberg tumor is present and associated with benign ascites and right hydrothorax, it is referred to as Pseudo-Meig syndrome.<xref ref-type="bibr" rid="article-23953.r17">[17]</xref>&#x000a0;Ovarian or adnexal torsion can result from tumor burden.<xref ref-type="bibr" rid="article-23953.r22">[22]</xref>&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-23953.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The&#x000a0;discovery of Krukenberg metastasis often precedes the diagnosis of the primary tumor. Nonspecific symptoms may&#x000a0;prompt&#x000a0;a computed tomography (CT) as the initial imaging modality, but if the lesion is first identified via ultrasound, follow-up&#x000a0;via CT or magnetic resonance imaging (MRI) can further define the ovarian process and&#x000a0;possibly identify the primary site. It is imperative to differentiate between a primary ovarian versus metastatic malignancy, as prognosis and treatment are markedly different. One recent meta-analysis of Krukenberg tumors found that almost half&#x000a0;of Krukenberg tumors were present on the same side as the primary tumor, two-thirds were bilateral, one-third had a diameter &#x0003e;10 cm, and half showed peritoneal involvement, often with ascites.<xref ref-type="bibr" rid="article-23953.r11">[11]</xref></p>
        <p>Ultrasound reveals&#x000a0;solid, cystic, or mixed bilateral ovarian masses&#x000a0;featuring well-defined margins and a moth-eaten cystic appearance, with a vascular pattern consisting of a main trunk vessel within the central portion of the mass and branching accessory vessels. The sonographic presentation of Krukenberg tumor&#x000a0;contrasts&#x000a0;with a primary ovarian tumor, which tends to be poorly demarcated with irregular thick septations.<xref ref-type="bibr" rid="article-23953.r4">[4]</xref>&#x000a0;</p>
        <p>CT can delineate the extent of metastatic spread, help locate the primary tumor, and identify any intraabdominal adenopathy. When seeking the tissue of origin, particular attention is paid to the stomach, biliary tract, pancreas, colon, and appendix. Krukenberg tumor presented on an MRI features sharply demarcated ovoid tumors with cystic bodies, hypointense T2 solid areas secondary to the stromal reaction, and hyperintense T2 cystic regions due to mucin content.</p>
        <p>Biopsies of any suspicious sites identified radiographically are imperative. National Comprehensive Cancer Network (NCCN)&#x000a0;guidelines for Krukenberg tumor evaluation include a thorough evaluation of the gastrointestinal tract, including esophagogastroduodenoscopy (EGD), colonoscopy, and evaluation of tissue for tumor markers. Specifically, a negative cytokeratin 7 (CK7)&#x000a0;stain and a positive&#x000a0;cytokeratin 20 (CK20) stain or concordant CK7 and CK20 positive stains suggest metastatic gastrointestinal cancer. An elevated CEA in an ovarian tumor also suggests a metastatic process. An elevated CA-125 in the setting of Krukenberg tumor&#x000a0;can be used as a surrogate to determine completeness of resection, indicate the presence of metachronous metastasis from a known primary, and help determine overall prognosis. One study showed that CA-125 levels &#x0003e;75 U/mL were associated with decreased survival at 5 years.<xref ref-type="bibr" rid="article-23953.r1">[1]</xref><xref ref-type="bibr" rid="article-23953.r2">[2]</xref><xref ref-type="bibr" rid="article-23953.r23">[23]</xref></p>
      </sec>
      <sec id="article-23953.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There are no standardized treatment guidelines for Krukenberg tumors as these malignancies represent a heterogeneity of tumor biology, but the basis for treatment includes systemic chemotherapy and cytoreductive surgery. Krukenberg tumor is thought to be more chemoresistant than metastases in other sites so that metastasectomy may allow for greater efficacy of chemotherapy for the remaining disease burden. Oncologic teams utilize an arsenal of chemotherapy, surgery,&#x000a0; targeted immunotherapy, and radiation, often following protocol from the tissue of origin. Cytoreductive surgery is thought to improve overall survival compared with chemotherapy alone. Chemotherapy may be delivered in a neoadjuvant and/or adjuvant setting or concurrently with surgery in the form of hyperthermia intraperitoneal chemotherapy (HIPEC).<xref ref-type="bibr" rid="article-23953.r24">[24]</xref><xref ref-type="bibr" rid="article-23953.r5">[5]</xref><xref ref-type="bibr" rid="article-23953.r25">[25]</xref></p>
      </sec>
      <sec id="article-23953.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Krukenberg tumors must be differentiated from primary ovarian malignancies and other metastatic processes, such as mucinous carcinoids. Carcinoids stain positive for chromogranin and synaptophysin, differentiating them from Krukenberg tumors. Although there can be similarities in gross appearance&#x000a0;between primary ovarian and Krukenberg&#x000a0;tumors, the malignancies can be distinguished using histologic and immunohistochemical analyses. Accurate identification and classification are important due to the significant differences in treatment and prognoses.</p>
        <p>Primary ovarian tumors&#x000a0;containing mucin are often unilateral. Primary ovarian tumors contain signet ring cells without mucin, including benign signet-ring stromal tumors, sclerosing stromal cell tumors, and clear cell ovarian adenocarcinoma, which stain negative for periodic acid-Schiff-Alcian blue. Tubular Krukenberg tumors must be distinguished from primary ovarian tumors with an annular or tubular pattern, including Sertoli-Leydig cell tumors, endometrioid carcinoma,&#x000a0;and tumors of Wolffian&#x000a0;origin.&#x000a0;One recent comparative study revealed that primary&#x000a0;ovarian cancer is often strongly positive for cytokeratin 7 (CK7) and negative for cytokeratin 20 (CK20), whereas Krukenberg tumor&#x000a0;is positive for CK20 or both CK20 and CK7.<xref ref-type="bibr" rid="article-23953.r1">[1]</xref><xref ref-type="bibr" rid="article-23953.r2">[2]</xref>&#x000a0;</p>
        <p>Primary ovarian cancer patients are usually&#x000a0;diagnosed at 65 years of age versus&#x000a0;younger than 50 years of age for Krukenberg patients.<xref ref-type="bibr" rid="article-23953.r26">[26]</xref>&#x000a0;The CA-125 tumor marker is usually&#x000a0;higher in primary ovarian cancer than in Krukenberg tumors. Median CA-125 levels are 652 u/mL for the former and 43 u/mL for the latter. Both CEA and cancer antigen 19-9 (CA19-9) are, on average, higher in Krukenberg tumors than in primary ovarian malignancies: 5.4 ng/mL (CEA) and 65.9 u/mL (CA19-9) vs 1.4 ng/mL (CEA) and 18.0 u/mL (CA19-9) respectively.&#x000a0;</p>
      </sec>
      <sec id="article-23953.s11" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <p>The mainstay of therapy for Krukenberg tumor remains R0 surgical resection,&#x000a0;defined as a microscopically negative margin of resection where no gross or microscopic tumor is found at the surgical site.<xref ref-type="bibr" rid="article-23953.r27">[27]</xref>&#x000a0;Prophylactic bilateral oophorectomy is advocated in the setting of unilateral disease.&#x000a0;Retrospective analysis showed patients with Krukenberg tumor who underwent palliative surgery, including a unilateral or bilateral salpingo-oophorectomy&#x000a0;alone or a total hysterectomy&#x000a0;combined with bilateral salpingo-oophorectomy, had a median overall survival of 17 months.<xref ref-type="bibr" rid="article-23953.r6">[6]</xref><xref ref-type="bibr" rid="article-23953.r8">[8]</xref><xref ref-type="bibr" rid="article-23953.r28">[28]</xref><xref ref-type="bibr" rid="article-23953.r29">[29]</xref>&#x000a0;Survival is improved in patients with primary gastric or colon cancers and Krukenberg tumors when complete resection of both the primary tumor and the metastatic ovarian tumor is accomplished.<xref ref-type="bibr" rid="article-23953.r4">[4]</xref><xref ref-type="bibr" rid="article-23953.r13">[13]</xref><xref ref-type="bibr" rid="article-23953.r30">[30]</xref><xref ref-type="bibr" rid="article-23953.r31">[31]</xref></p>
        <p>Retrospective studies demonstrate improvement in overall survival for those patients who undergo metastasectomy for Krukenberg tumor compared with systemic chemotherapy alone.<xref ref-type="bibr" rid="article-23953.r13">[13]</xref><xref ref-type="bibr" rid="article-23953.r31">[31]</xref><xref ref-type="bibr" rid="article-23953.r32">[32]</xref>&#x000a0;A recent small study examined the efficacy of surgery in patients with gastric cancer and synchronous ovarian metastases.&#x000a0;The patients underwent resection of ovarian metastases, either alone or in conjunction with gastric resection and lymph node dissection, either before&#x000a0;or following systemic and/or hyperthermic intraperitoneal chemotherapy (HIPEC). Median overall survival was significantly greater in those patients who underwent excision before systemic chemotherapy compared to those&#x000a0;who underwent&#x000a0;simultaneous gastrectomy and metastasectomy following chemotherapy.&#x000a0;Using HIPEC improved overall survival in those patients with peritoneal metastases.<xref ref-type="bibr" rid="article-23953.r33">[33]</xref></p>
      </sec>
      <sec id="article-23953.s12" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>Studies on Krukenberg tumors have examined how treatment approaches impact progression-free and overall survival. Other&#x000a0;research focuses on improving diagnostic capability, and still other studies focus on identifying promising targets for directed therapy.&#x000a0;Several small studies compared combination chemotherapy regimens in conjunction with cytoreductive surgery with the addition of radiotherapy on occasion. The overall trend is toward prolonged progression-free and overall survival in those patients who undergo more aggressive therapy.<xref ref-type="bibr" rid="article-23953.r5">[5]</xref>&#x000a0;In 2018, Haiyan et al examined programmed death-ligand 1 expression in Krukenberg tumors as a potential therapy target.<xref ref-type="bibr" rid="article-23953.r34">[34]</xref></p>
        <p>Huang et al examined the distribution and type of tumor-associated macrophages within primary and metastatic sites in patients with Krukenberg tumor from a gastric primary as an indicator of responsiveness to chemotherapy. Results suggest that Krukenberg tumors are relatively insensitive to chemotherapy and that metastasectomy before chemotherapy improves survival.<xref ref-type="bibr" rid="article-23953.r9">[9]</xref>&#x000a0;</p>
        <p>In a recent case study, a 34-year-old woman with Krukenberg of colorectal origin was treated with cytoreductive surgery and postoperative chemotherapy, consisting of capecitabine and oxaliplatin, with disease-free survival noted in a 3-year follow-up.<xref ref-type="bibr" rid="article-23953.r35">[35]</xref>&#x000a0;A 76-year-old woman with Krukenberg from a colorectal primary was deemed unresectable. Failing a second line of systemic chemotherapy, she received a high fractional dose radiation with subsequent 4-year survival, 2 of which were progression-free.<xref ref-type="bibr" rid="article-23953.r13">[13]</xref></p>
        <p>Xie et al proposed an algorithm based on neural network modeling, an artificial intelligence (AI) paradigm, to improve the discrimination of Krukenberg from primary ovarian cancer. In this model, biochemical and clinical features are added to a preexisting radiographic algorithm to improve the diagnostic accuracy of AI modeling for Krukenberg tumors.<xref ref-type="bibr" rid="article-23953.r26">[26]</xref></p>
      </sec>
      <sec id="article-23953.s13" sec-type="Medical Oncology">
        <title>Medical Oncology</title>
        <p>Chemotherapy regimens are based on the tissue of origin, and national and international guidelines specific to the primary cancer should be referred to. Regimens often include 5<italic toggle="yes">-</italic>fluorouracil (5-FU), either as a monotherapy or in combination with taxanes and a platinum. When molecular data from the tumor reveal a mutation for which a drug has been synthesized, such as overexpression of human epidermal growth factor receptor 2 (HER2), targeted therapy such as trastuzumab (Herceptin) is used.&#x000a0;</p>
        <p>Cytoreductive surgery is thought to increase the responsiveness of chemotherapy in patients with Krukenberg tumors. Chemotherapy alone has less impact on overall survival than metastasectomy. Adjuvant systemic chemotherapy confers a survival benefit in those patients with Krukenberg able to first undergo surgery, and HIPEC has been shown to prolong disease-free survival in those with peritoneal metastases.<xref ref-type="bibr" rid="article-23953.r24">[24]</xref><xref ref-type="bibr" rid="article-23953.r36">[36]</xref><xref ref-type="bibr" rid="article-23953.r37">[37]</xref></p>
      </sec>
      <sec id="article-23953.s14" sec-type="Staging">
        <title>Staging</title>
        <p>Krukenberg tumor is, by definition, classified as stage IV disease.</p>
      </sec>
      <sec id="article-23953.s15" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients with Krukenberg tumors frequently do not survive beyond 2 years.<xref ref-type="bibr" rid="article-23953.r23">[23]</xref>&#x000a0;The median overall survival is reported to be 14 months, and the median survival by tissue of origin is reportedly 11, 21.5, 31, and 19.5 months for gastric, colorectal, breast, and other sites, respectively.<xref ref-type="bibr" rid="article-23953.r38">[38]</xref><xref ref-type="bibr" rid="article-23953.r23">[23]</xref>&#x000a0;Patients with unilateral Krukenberg tumors fare better, as do those who undergo successful R0 resection. Colorectal cancer has better survival data than gastric cancer, particularly when HIPEC is added to R0 resection.<xref ref-type="bibr" rid="article-23953.r22">[22]</xref><xref ref-type="bibr" rid="article-23953.r24">[24]</xref><xref ref-type="bibr" rid="article-23953.r39">[39]</xref></p>
        <p>Metastasectomy, expressive estrogen receptor beta, progesterone receptor, and signet-ring cells are independent predictors of survival.<xref ref-type="bibr" rid="article-23953.r29">[29]</xref>&#x000a0;For gastric cancer subtypes, the presence of the tyrosine kinase receptor Erb and progesterone receptor confers a better prognosis in patients with synchronous tumors.&#x000a0;Factors related to a worse prognosis include synchronous presentation of tumors, ascites burden, high CEA and programmed cell death ligand 1 (PD-L1) levels, peritoneal involvement, and lymphovascular invasion.<xref ref-type="bibr" rid="article-23953.r29">[29]</xref></p>
        <p>Tumor markers&#x000a0;are helpful in gauging response to therapy.<xref ref-type="bibr" rid="article-23953.r8">[8]</xref>&#x000a0;CA-125 levels fall following tumor resection and may be followed as an indicator of recurrence. Rising levels in the preoperative period may signify a metastatic process. Also, the preoperative absolute value of CA-125 may be a prognostic indicator.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-23953.s16" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of Krukenberg tumors may include ovarian torsion and small bowel obstruction.</p>
      </sec>
      <sec id="article-23953.s17" sec-type="Consultations">
        <title>Consultations</title>
        <p>The care of patients with Krukenberg tumors relies on medical, surgical, and radiation oncology expertise.</p>
      </sec>
      <sec id="article-23953.s18" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education plays a vital role in raising awareness, promoting early detection, and ensuring that individuals are informed about the management of and potential outcomes associated with Krukenberg tumors. Educational emphasis should be on promoting an understanding of how this metastatic tumor differs from primary ovarian cancer.</p>
        <p>Patients should be educated about the signs and symptoms of cancers affecting the ovaries, the risk factors for developing Krukenberg tumors, and the importance of adherence to screening recommendations such as colonoscopies and mammograms. It is important to encourage women to seek medical attention promptly if they experience symptoms such as abdominal pain, bloating, unusual vaginal bleeding, changes in bowel habits, or other signs associated with&#x000a0;cancer affecting the ovaries.</p>
      </sec>
      <sec id="article-23953.s19" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Immunohistochemical analysis may be required to distinguish a Krukenberg tumor from a primary ovarian malignancy, and this distinction is crucial for treatment and prognosis. Cytoreductive surgery is shown to be associated with an overall survival benefit in patients with Krukenberg tumor, but no formal guidelines exist for comprehensive care of the patient with Krukenberg tumor.&#x000a0;</p>
      </sec>
      <sec id="article-23953.s20" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of patients with Krukenbergy tumors are complex and&#x000a0;require a collaborative&#x000a0;interprofessional team, including physicians, advanced care practitioners, pharmacists, nutritionists, and other healthcare professionals. Specialized care in the form of hospice, palliative care, pain specialists, medical, surgical, and radiation oncology, as well as pathology, is essential. It is crucial to develop a strategic approach based on the origin of the primary tumor, the patient's functional status,&#x000a0;and the patient's autonomy.&#x000a0;&#x000a0;</p>
        <p>The interprofessional team is important in enhancing patient comfort and quality of life. Informed consent is essential, respects patient autonomy, and ensures beneficence.&#x000a0;Shared decision-making elevates the voices of the patient and family. Patients are frequently debilitated, and many benefit from hospice care. Most patients do not survive more than 12&#x000a0;to 24 months&#x000a0;independent of treatment, although cytoreductive surgery may prolong survival.<xref ref-type="bibr" rid="article-23953.r19">[19]</xref><xref ref-type="bibr" rid="article-23953.r6">[6]</xref>&#x000a0;&#x000a0;</p>
        <p>Effective communication among team members is essential for coordinated care. This involves regular team meetings, clear documentation of care plans, and timely sharing of patient information. Open communication channels facilitate the exchange of ideas, enhance patient safety, and prevent errors.&#x000a0;Ongoing professional development ensures that healthcare&#x000a0;professionals are equipped to provide optimal care. By working collaboratively, healthcare professionals can provide comprehensive, patient-centered care for individuals with Kruckenberg tumors, ultimately improving outcomes and overall team performance.</p>
      </sec>
      <sec id="article-23953.s21">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23953&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23953">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/krukenberg-tumor/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23953">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23953/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23953">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23953.s22">
        <title>References</title>
        <ref id="article-23953.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kube&#x0010d;ek</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Laco</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>&#x00160;pa&#x0010d;ek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Petera</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kopeck&#x000fd;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kube&#x0010d;kov&#x000e1;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Filip</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review.</article-title>
            <source>Clin Exp Metastasis</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>295</fpage>
            <page-range>295-307</page-range>
            <pub-id pub-id-type="pmid">28730323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Agha</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Nicastri</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>An in-depth look at Krukenberg tumor: an overview.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>130</volume>
            <issue>11</issue>
            <fpage>1725</fpage>
            <page-range>1725-30</page-range>
            <pub-id pub-id-type="pmid">17076540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bennett</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Oliva</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Pathology of the adnexal mass.</article-title>
            <source>Clin Obstet Gynecol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-27</page-range>
            <pub-id pub-id-type="pmid">25608250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zulfiqar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nougaret</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bolan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>VanBuren</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>McGettigan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Menias</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Krukenberg Tumors: Update on Imaging and Clinical Features.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>215</volume>
            <issue>4</issue>
            <fpage>1020</fpage>
            <page-range>1020-1029</page-range>
            <pub-id pub-id-type="pmid">32755184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Xue</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Metastasectomy Improves the Survival of Gastric Cancer Patients with Krukenberg Tumors: A Retrospective Analysis of 182 patients.</article-title>
            <source>Cancer Manag Res</source>
            <year>2019</year>
            <volume>11</volume>
            <fpage>10573</fpage>
            <page-range>10573-10580</page-range>
            <pub-id pub-id-type="pmid">31908529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seow-En</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hwarng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>GHC</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>LML</given-names>
              </name>
              <name>
                <surname>Teo</surname>
                <given-names>MCC</given-names>
              </name>
            </person-group>
            <article-title>Palliative surgery for Krukenberg tumors - 12-year experience and review of the literature.</article-title>
            <source>World J Clin Oncol</source>
            <year>2018</year>
            <month>Feb</month>
            <day>10</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-19</page-range>
            <pub-id pub-id-type="pmid">29468133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cr&#x00103;ciun</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Dom&#x0015f;a</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemical diagnosis of Krukenberg tumors.</article-title>
            <source>Rom J Morphol Embryol</source>
            <year>2017</year>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>845</fpage>
            <page-range>845-849</page-range>
            <pub-id pub-id-type="pmid">29250663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaur</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Vijayakumar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kumbhar</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Nachiappa Ganesh</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Intestinal Obstruction Due to Giant Bilateral Krukenberg's Tumors Synchronous of Colorectal Origin.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Mar</month>
            <day>29</day>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>e14176</fpage>
            <pub-id pub-id-type="pmid">33936887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mo</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Invasion characteristics and clinical significance of tumor-associated macrophages in gastrointestinal Krukenberg tumors.</article-title>
            <source>Front Oncol</source>
            <year>2023</year>
            <volume>13</volume>
            <fpage>1006183</fpage>
            <pub-id pub-id-type="pmid">36910657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhuo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin.</article-title>
            <source>J Gastrointest Oncol</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>1022</fpage>
            <page-range>1022-1034</page-range>
            <pub-id pub-id-type="pmid">35837152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lionetti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>DE Luca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raffone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Travaglino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Coppellotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peltrini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bracale</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>D'Ambra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Insabato</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zullo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>D'Armiento</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Corcione</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Clinics and pathology of Krukenberg tumor: a systematic review and meta-analysis.</article-title>
            <source>Minerva Obstet Gynecol</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>74</volume>
            <issue>4</issue>
            <fpage>356</fpage>
            <page-range>356-363</page-range>
            <pub-id pub-id-type="pmid">33944524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mitra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jena</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Krukenberg Tumor of Ovary During Pregnancy: Learning From A Mistake.</article-title>
            <source>Int J Gynecol Pathol</source>
            <year>2021</year>
            <month>Nov</month>
            <day>01</day>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>617</fpage>
            <page-range>617-620</page-range>
            <pub-id pub-id-type="pmid">33252404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Effect of metastasectomy on the outcome of patients with ovarian metastasis of colorectal cancer: A systematic review and meta-analysis.</article-title>
            <source>Eur J Surg Oncol</source>
            <year>2023</year>
            <month>Sep</month>
            <volume>49</volume>
            <issue>9</issue>
            <fpage>106961</fpage>
            <pub-id pub-id-type="pmid">37355393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tuzcu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>S&#x000fc;tc&#x000fc;o&#x0011f;lu</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bayram</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Erdem</surname>
                <given-names>&#x000d6;</given-names>
              </name>
              <name>
                <surname>Yaz&#x00131;c&#x00131;</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Krukenberg Tumor Presentation of Recurrent Gallbladder Cancer After a Decade.</article-title>
            <source>J Gastrointest Cancer</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>264</fpage>
            <page-range>264-267</page-range>
            <pub-id pub-id-type="pmid">34799819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sakio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ota</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tahara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koinuma</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Horie</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lefor</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sata</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Metachronous Krukenberg tumor from adenocarcinoma in a Meckel's diverticulum: a case report.</article-title>
            <source>J Surg Case Rep</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>2021</volume>
            <issue>8</issue>
            <fpage>rjab374</fpage>
            <pub-id pub-id-type="pmid">34476080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujimoto</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hirono</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Goi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sigmoid colonic metastasis by lymphatic spread occurring with unilateral Krukenberg tumor considered to be caused by stage IA early gastric cancer: A case report.</article-title>
            <source>Oncol Lett</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>668</fpage>
            <page-range>668-672</page-range>
            <pub-id pub-id-type="pmid">26870264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sandhu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arafat</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lall</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Krukenberg tumor: a rare cause of ovarian torsion.</article-title>
            <source>J Clin Imaging Sci</source>
            <year>2012</year>
            <volume>2</volume>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">22439130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Karn</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Transcoelomic spread and ovarian seeding during ovulation: A possible pathogenesis of Krukenberg tumor.</article-title>
            <source>J Cancer Res Ther</source>
            <year>2017</year>
            <season>Jan-Mar</season>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>152</fpage>
            <page-range>152-153</page-range>
            <pub-id pub-id-type="pmid">28508852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agnes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Biondi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gallotta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>D'Ugo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Persiani</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Krukenberg tumors: Seed, route and soil.</article-title>
            <source>Surg Oncol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>438</fpage>
            <page-range>438-445</page-range>
            <pub-id pub-id-type="pmid">29113663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goidescu</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Nemeti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Preda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Surcel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eniu</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Cruciat</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mure&#x00219;an</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Krukenberg tumor in pregnancy: a rare case and review of the literature.</article-title>
            <source>J Matern Fetal Neonatal Med</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>25</issue>
            <fpage>7290</fpage>
            <page-range>7290-7295</page-range>
            <pub-id pub-id-type="pmid">34470118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendoza-Rosado</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nunez-Isaac</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Espinosa-Marr&#x000f3;n</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lopez-Arjona</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Davila-Martinez</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Krukenberg tumor as an incidental finding in a full-term pregnancy: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2021</year>
            <month>May</month>
            <day>29</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>304</fpage>
            <pub-id pub-id-type="pmid">34049591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeung</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Ok</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Krukenberg tumors of gastric origin versus colorectal origin.</article-title>
            <source>Obstet Gynecol Sci</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <page-range>32-9</page-range>
            <pub-id pub-id-type="pmid">25629016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Eu</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>Krukenberg tumors of colorectal origin: a dismal outcome--experience of a tertiary center.</article-title>
            <source>Int J Colorectal Dis</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>233</fpage>
            <page-range>233-8</page-range>
            <pub-id pub-id-type="pmid">19705132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bignell</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Alves</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chandrakumaran</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dayal</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cecil</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.</article-title>
            <source>Colorectal Dis</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>8</issue>
            <fpage>704</fpage>
            <page-range>704-710</page-range>
            <pub-id pub-id-type="pmid">29502336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Namikawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Marui</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yokota</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kawanishi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Munekage</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Uemura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kitagawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanazaki</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Frequency and therapeutic strategy for patients with ovarian metastasis from gastric cancer.</article-title>
            <source>Langenbecks Arch Surg</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>407</volume>
            <issue>6</issue>
            <fpage>2301</fpage>
            <page-range>2301-2308</page-range>
            <pub-id pub-id-type="pmid">35551466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xie</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Erickson</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Sheedy</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hubbard</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>The diagnosis and outcome of Krukenberg tumors.</article-title>
            <source>J Gastrointest Oncol</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>226</fpage>
            <page-range>226-236</page-range>
            <pub-id pub-id-type="pmid">34012621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aurello</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Berardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Antolino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rampini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moschetta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ramacciato</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Is a Surgical Approach Justified in Metachronous Krukenberg Tumor from Gastric Cancer? A Systematic Review.</article-title>
            <source>Oncol Res Treat</source>
            <year>2018</year>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>644</fpage>
            <page-range>644-649</page-range>
            <pub-id pub-id-type="pmid">30205375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ying</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Treatment strategy and prognostic factors for Krukenberg tumors of gastric origin: report of a 10-year single-center experience from China.</article-title>
            <source>Oncotarget</source>
            <year>2017</year>
            <month>Oct</month>
            <day>10</day>
            <volume>8</volume>
            <issue>47</issue>
            <fpage>82558</fpage>
            <page-range>82558-82570</page-range>
            <pub-id pub-id-type="pmid">29137284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Management Of Synchronous Krukenberg Tumors From Gastric Cancer: a Single-center Experience.</article-title>
            <source>J Cancer</source>
            <year>2018</year>
            <volume>9</volume>
            <issue>22</issue>
            <fpage>4197</fpage>
            <page-range>4197-4203</page-range>
            <pub-id pub-id-type="pmid">30519320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beyer</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Surgery Matters: Progress in Surgical Management of Gastric Cancer.</article-title>
            <source>Curr Treat Options Oncol</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>108</fpage>
            <page-range>108-129</page-range>
            <pub-id pub-id-type="pmid">36656504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>ERRATUM: Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor.</article-title>
            <source>Cancer Res Treat</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>302</fpage>
            <pub-id pub-id-type="pmid">29216420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor.</article-title>
            <source>Cancer Res Treat</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>697</fpage>
            <page-range>697-705</page-range>
            <pub-id pub-id-type="pmid">25648093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Chai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of chemotherapy combined with surgical resection for gastric cancer with synchronous ovarian metastasis: A propensity score matching analysis.</article-title>
            <source>Cancer Med</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>12</volume>
            <issue>16</issue>
            <fpage>17126</fpage>
            <page-range>17126-17138</page-range>
            <pub-id pub-id-type="pmid">37519112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Xi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>PD-L1 Expression Predicts a Distinct Prognosis in Krukenberg Tumor with Corresponding Origins.</article-title>
            <source>J Immunol Res</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>9485285</fpage>
            <pub-id pub-id-type="pmid">29854854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arr&#x000f3; Ortiz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ramallo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guerrini</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>What is the ideal management of Krukenberg syndrome?</article-title>
            <source>J Surg Case Rep</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>2022</volume>
            <issue>7</issue>
            <fpage>rjac328</fpage>
            <pub-id pub-id-type="pmid">35813457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Georgescu</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Turcule&#x00163;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Georgescu</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Georgescu</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>P&#x00103;tra&#x0015f;cu</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment Difficulties in a Case of Synchronous Colon Cancer with Ovarian Metastasis and Peritoneal Carcinomatosis.</article-title>
            <source>Chirurgia (Bucur)</source>
            <string-date>2023 Sept</string-date>
            <volume>118</volume>
            <issue>eCollection</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">37750317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lionetti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>De Luca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Travaglino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raffone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Insabato</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Saccone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mascolo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'armiento</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zullo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Corcione</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Treatments and overall survival in patients with Krukenberg tumor.</article-title>
            <source>Arch Gynecol Obstet</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>300</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-23</page-range>
            <pub-id pub-id-type="pmid">31044302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Mi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>LU</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics and prognostic analysis of Krukenberg tumor.</article-title>
            <source>Mol Clin Oncol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>1323</fpage>
            <page-range>1323-1328</page-range>
            <pub-id pub-id-type="pmid">26807242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23953.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zang</surname>
                <given-names>RY</given-names>
              </name>
            </person-group>
            <article-title>Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors.</article-title>
            <source>Eur J Surg Oncol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>92</fpage>
            <page-range>92-7</page-range>
            <pub-id pub-id-type="pmid">18632244</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
